» Articles » PMID: 1662805

Structural Analysis of the Human Papillomavirus Type 16-E2 Transactivator with Antipeptide Antibodies Reveals a High Mobility Region Linking the Transactivation and the DNA-binding Domains

Overview
Specialty Biochemistry
Date 1991 Dec 1
PMID 1662805
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

In order to probe the structure of the transcription factor encoded by the E2 Open Reading Frame of papillomaviruses, we raised polyclonal antibodies against a series of synthetic peptides that cover the HPV16-E2 protein. In gel shift experiments with the native form of the protein, we detected supershifts (caused by the binding of antibodies to the E2-DNA complex) with antibodies synthesized against peptides covering a central region 50 residues long in the E2 protein. On the contrary, antibodies raised against peptides from the NH2- and COOH-termini did not give any supershifted band. Western blot experiments showed that several of these non reacting antibodies did however interact with the denatured protein. These results suggest that the central region that connects the NH2-terminal domain responsible for transcriptional activation and the COOH-domain involved in DNA-binding is exposed and maintained in a conformation resembling the peptide, indicating a high mobility region. In contrast, the DNA-binding and transactivation domains were not recognized by the antipeptide antibodies, in line with secondary structure predictions and sequence comparisons indicating that the E2 protein consists of structured and conserved NH2 and COOH-terminal regions separated by a non-conserved and unstructured region. This flexible 'hinge' region may facilitate contacts between E2 dimers at distance in mechanisms of transcriptional activation steps that involve homosynergy or DNA-looping.

Citing Articles

Sequence-Dependent Interaction of the Human Papillomavirus E2 Protein with the DNA Elements on Its DNA Replication Origin.

Yilmaz G, Biswas-Fiss E, Biswas S Int J Mol Sci. 2023; 24(7).

PMID: 37047526 PMC: 10095481. DOI: 10.3390/ijms24076555.


Targeted Next Generation Sequencing for Human Papillomavirus Genotyping in Cervical Liquid-Based Cytology Samples.

Andersen K, Holm K, Tranberg M, Pedersen C, Bonlokke S, Steiniche T Cancers (Basel). 2022; 14(3).

PMID: 35158920 PMC: 8833452. DOI: 10.3390/cancers14030652.


A proteomic approach to discover and compare interacting partners of papillomavirus E2 proteins from diverse phylogenetic groups.

Jang M, Anderson D, Van Doorslaer K, McBride A Proteomics. 2015; 15(12):2038-50.

PMID: 25758368 PMC: 4535189. DOI: 10.1002/pmic.201400613.


The papillomavirus E2 proteins.

McBride A Virology. 2013; 445(1-2):57-79.

PMID: 23849793 PMC: 3783563. DOI: 10.1016/j.virol.2013.06.006.


Type-specific interaction between human papillomavirus type 58 E2 protein and E7 protein inhibits E7-mediated oncogenicity.

Wang X, Qi M, Yu X, Yuan Y, Zhao W J Gen Virol. 2012; 93(Pt 7):1563-1572.

PMID: 22442110 PMC: 3542735. DOI: 10.1099/vir.0.039354-0.


References
1.
Tainer J, Getzoff E, Paterson Y, Olson A, Lerner R . The atomic mobility component of protein antigenicity. Annu Rev Immunol. 1985; 3:501-35. DOI: 10.1146/annurev.iy.03.040185.002441. View

2.
Van Regenmortel M, Daney de Marcillac G . An assessment of prediction methods for locating continuous epitopes in proteins. Immunol Lett. 1988; 17(2):95-107. DOI: 10.1016/0165-2478(88)90076-4. View

3.
Houghten R . General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids. Proc Natl Acad Sci U S A. 1985; 82(15):5131-5. PMC: 390513. DOI: 10.1073/pnas.82.15.5131. View

4.
Molla A, Charbit A, Le Guern A, RYTER A, Hofnung M . Antibodies against synthetic peptides and the topology of LamB, an outer membrane protein from Escherichia coli K12. Biochemistry. 1989; 28(20):8234-41. DOI: 10.1021/bi00446a040. View

5.
McBride A, Byrne J, Howley P . E2 polypeptides encoded by bovine papillomavirus type 1 form dimers through the common carboxyl-terminal domain: transactivation is mediated by the conserved amino-terminal domain. Proc Natl Acad Sci U S A. 1989; 86(2):510-4. PMC: 286500. DOI: 10.1073/pnas.86.2.510. View